CORRECTED-U.S. FDA warns Avon to smooth out claims on skin care products
(Removes paragraph with incorrect reference to CEO start date)
Oct 16 (Reuters) - The U.S. Food and Drug Administration warned beauty products company Avon Products Inc to stop advertising its Anew range of skin care products using language that makes them sound like drugs.
In September, the regulator had warned L'Oreal SA for making similar claims.
The FDA reviewed the company's website in August, and objected to claims made about the products Anew Clinical Advanced Wrinkle Corrector, Anew Reversalist Night Renewal Cream, Anew Reversalist Renewal Serum, Anew Clinical Thermafirm Face Lifting Cream, and Solutions Liquid Bra Toning Gel.
The regulator warned Avon in a letter dated Oct. 5 that the claims on the company's website implied those products were intended to affect the structure or function of the human body, which would classify them as drugs.
The letter was posted on the FDA's website on Tuesday. (link.reuters.com/qug43t)
Avon was not immediately available for comment outside of U.S. business hours. (Reporting by Krithika Krishnamurthy in Bangalore; Editing by Chris Gallagher)
- U.S. war veteran released by North Korea returns home |
- Pennsylvania newlyweds "just wanted to murder someone together:" police
- U.S. ice storm causes blackouts, delays in Texas, Arkansas
- WTO overcomes last minute hitch to reach its first global trade deal
- China's parliament: Japan has "no right to criticize" air defense zone